Skip to main content
ARS Home » Midwest Area » Ames, Iowa » National Animal Disease Center » Virus and Prion Research » Research » Publications at this Location » Publication #367599

Research Project: Non-Antibiotic Strategies to Control Priority Bacterial Infections in Swine

Location: Virus and Prion Research

Title: Evaluation of the recombinant proteins RlpB and VacJ as a vaccine for protection against Glaesserella parasuis in pigs

item HAU, SAMANTHA - Oak Ridge Institute For Science And Education (ORISE)
item LUAN, SHI-LU - University Of Cambridge
item Loving, Crystal
item Nicholson, Tracy
item WANG, JINHONG - University Of Cambridge
item PETERS, SARAH - University Of Cambridge
item SEILLY, DAVID - University Of Cambridge
item WEINERT, LUCY - University Of Cambridge
item LANGFORD, PAUL - Imperial College
item RYCROFT, ANDREW - University Of Cambridge
item WREN, BRENDAN - London School Of Hygiene & Tropical Medicine
item MASKELL, DUNCAN - University Of Cambridge
item TUCKER, ALEXANDER - University Of Cambridge
item Brockmeier, Susan

Submitted to: BMC Veterinary Research
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: 5/14/2020
Publication Date: 5/28/2020
Publication URL:
Citation: Hau, S.J., Luan, S., Loving, C.L., Nicholson, T.L., Wang, J., Peters, S.E., Seilly, D., Weinert, L., Langford, P.R., Rycroft, A., Wren, B.W., Maskell, D.J., Tucker, A.W., Brockmeier, S. 2020. Evaluation of the recombinant proteins RlpB and VacJ as a vaccine for protection against Glaesserella parasuis in pigs. BMC Veterinary Research. 16:167.

Interpretive Summary: Glaesserella parasuis causes severe disease in pigs. It is difficult to prevent because vaccines do not prevent disease with all strains. There is now focus on developing vaccines from G. parasuis proteins. Protein vaccines could provide protection against many strains. We identified and evaluated the use of two G. parasuis proteins as vaccine candidates (RlpB and VacJ). The proteins induced high antibody levels, however, these antibodies were not able to protect pigs from challenge with G. parasuis. We think the reason the vaccine was not protective was because there isn’t enough RlpB and VacJ exposed on G. parasuis for the antibody to prevent disease.

Technical Abstract: Glaesserella parasuis, the causative agent of Glasser’s disease, is widespread in swine globally resulting in significant economic losses to the swine industry. Prevention of Glasser’s disease in pigs has been plagued with an inability to design broadly protective vaccines, as many bacterin based platforms generate serotype or strain specific immunity. Subunit vaccines are of interest to provide protective immunity to multiple strains of G. parasuis. Selected proteins for subunit vaccination should be widespread, highly conserved, and surface exposed. In this report, we report the identification of two candidate proteins for subunit vaccination (RlpB and VacJ) and evaluate recombinant RlpB and VacJ, outer membrane proteins with important contributions to cellular function and viability, as subunit vaccine candidates. Though high antibody titers to the recombinant proteins and increased interferon-gamma producing cells were found in subunit vaccinated animals, the pigs were not protected from developing systemic disease. It appears likely insufficient RlpB and VacJ are expressed on the bacterial surface for antibody to bind, preventing high RlpB and VacJ specific antibody titers from protecting animals from G. parasuis.